drugset / Trial / NCT06077422

Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain

NCT06077422

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The goal of this pilot study is to describe and compare Ultrasound-Guided Erector Spinae Plane (ESP) Blocks using Exparel® (bupivacaine liposome injectable suspension) to Marcaine® (bupivacaine hydrochloride) for pain management and outcomes after cardiac surgeries.

Timeline

Start
2024-01-11
Primary completion
2027-01-11
Completion
2027-04-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified Other

Indications